Ubs Group Ag Hcw Biologics Inc. Transaction History
Ubs Group Ag
- $452 Billion
- Q3 2024
A detailed history of Ubs Group Ag transactions in Hcw Biologics Inc. stock. As of the latest transaction made, Ubs Group Ag holds 4,831 shares of HCWB stock, worth $1,884. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,831
Previous 4,285
12.74%
Holding current value
$1,884
Previous $2,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding HCWB
# of Institutions
17Shares Held
1.16MCall Options Held
0Put Options Held
0-
Avantax Planning Partners, Inc.280KShares$109,0200.01% of portfolio
-
Geode Capital Management, LLC Boston, MA183KShares$71,4710.0% of portfolio
-
High Tower Advisors, LLC Chicago, IL181KShares$70,5150.0% of portfolio
-
Cresset Asset Management, LLC Chicago, IL132KShares$51,4760.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX84.7KShares$33,0330.0% of portfolio
About HCW Biologics Inc.
- Ticker HCWB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,833,100
- Market Cap $14M
- Description
- HCW Biologics Inc., a preclinical stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases. The company's lead products include HCW9218, which is an injectable immunotherapeutic for patients with pancreatic, ovarian, breast, prostate, and colorectal...